PTCA or CABG in diabetes mellitus


Prof Sundeep Mishra, New Delhi    03 December 2017

Several pathophysiological factors confer high risk after revascularization. Trials reveal higher MACE after revascularization with PCI compared with CABG in patients with triple vessel disease. Most of this higher MACE is associated with the increased requirement of repeat procedure with PCI. However, this risk may not hold true for single vessel disease or with the latest generation of stents. The risks of death and target vessel MI with PCI are particularly high in insulin-dependent patients with diabetes. Even risk of stent thrombosis is higher in these patients. In patients with high surgical risk PCI still remains an option Newer antiplatelets are better than clopidogrel in patients with diabetes.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.